Inari Medical soars on Stryker acquisition
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
BTIG Downgrades Inari Medical Inc. (NARI) to Neutral
January 7, 2025 4:09 PM ESTBTIG analyst Marie Thibault downgraded Inari Medical Inc. (NASDAQ: NARI) from Buy to Neutral.
The analyst comments "We are downgrading NARI shares to Neutral following the announcement on Monday, January 6 that Stryker (SYK, Buy, $394 PT; Analyst: Zimmerman) entered a definitive agreement to... More
Jefferies Downgrades Inari Medical Inc. (NARI) to Hold
January 7, 2025 11:49 AM ESTJefferies analyst Matthew Taylor downgraded Inari Medical Inc. (NASDAQ: NARI) from Buy to Hold with a price target of $80.00 (from $70.00).
The analyst comments "After the market close, SYK announced an agreement to acquire NARI for $80/shr in cash, equating to a fully... More
BofA Securities Reiterates Buy Rating on Stryker (SYK)
January 7, 2025 8:07 AM ESTBofA Securities analyst Travis Steed reiterated a Buy rating and $450.00 price target on Stryker (NYSE: SYK)
The analyst comments "Inside we include our pro forma deal model. We estimate the EPS dilution in year 1 is only slightly dilutive (around 1-3% dilutive) and... More



